# Trial of EXenatide in Acute Ischaemic Stroke

Study · id `cardio:ct-nct03287076` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03287076](<https://clinicaltrials.gov/study/NCT03287076>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03287076

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 350 participants.

## Technical summary

Registry record NCT03287076. Randomized; single masking; primary purpose treatment. Start 2017-11-23 (actual); primary completion 2021-10-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 350 participants (enrolled count; ClinicalTrials.gov record NCT03287076, source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)
- Started: 2017-11-23 (actual) (ClinicalTrials.gov record NCT03287076, source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)
- Primary completion: 2021-10-04 (anticipated) (ClinicalTrials.gov record NCT03287076, source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT03287076, source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)
- Countries: Australia; Finland; New Zealand (ClinicalTrials.gov record NCT03287076, source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03287076-2021-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial of EXenatide in Acute Ischaemic Stroke
- Acronym: TEXAIS
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Exenatide Injection
- Lead sponsor: Neuroscience Trials Australia
- Lead sponsor class: OTHER
- Collaborator: National Health and Medical Research Council, Australia
- Collaborator class: OTHER
- Collaborator: Monash University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Neuroscience Trials Australia (`cardio:org-neuroscience-trials-australia`)
- Registry lists this organization as a collaborator: National Health and Medical Research Council, Australia (`cardio:org-national-health-and-medical-research-council-australia`)
- Registry lists this organization as a collaborator: Monash University (`cardio:org-monash-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial (`cardio:pubmed-38011235`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 645a0caa8d380d28aec0d63b6eb3ec86b0bab3762fe5c0c069fb897363237ec7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
